Signaling to the ribosome in cancer--It is more than just mTORC1

Katherine M Hannan1, Elaine Sanij, Nadine Hein

  • 1Growth Control and Differentiation Program, Peter MacCallum Cancer Centre, St. Andrews Place, East Melbourne, VIC, Australia.

IUBMB Life
|March 2, 2011
PubMed

Insights

Dysregulated protein synthesis, controlled by the ribosome, drives tissue overgrowth diseases. The PI3K/AKT/mTORC1 pathway is key to ribosome regulation in health and disease, offering therapeutic targets.

Area of Science:

  • Molecular Biology
  • Cellular Biology
  • Disease Pathogenesis

Background:

  • Dysregulation of protein synthesis is linked to diseases involving tissue overgrowth, such as cancer and cardiac hypertrophy.
  • The ribosome is a central regulator of protein synthesis, integrating signals from key growth pathways like RAS, MYC, and PI3K.
  • Coordinated control of ribosome synthesis and function is crucial for regulating cell growth and maintaining homeostasis.

Purpose of the Study:

  • To review the role of the PI3K/AKT/mammalian target of rapamycin complex 1 (mTORC1) pathway in ribosome regulation.
  • To explore the interplay between PI3K/AKT/mTORC1, RAS, and MYC pathways in controlling protein synthesis.
  • To discuss the therapeutic potential of targeting this regulatory network in disease.

Main Methods:

  • Literature review and synthesis of existing research on protein synthesis regulation.
  • Analysis of signaling pathways involved in ribosome biogenesis and function.
  • Examination of the connection between pathway dysregulation and disease phenotypes.

Main Results:

  • The PI3K/AKT/mTORC1 pathway plays a critical role in controlling ribosome biogenesis and protein synthesis rates.
  • Convergence of RAS, MYC, and PI3K signaling pathways on the ribosome ensures coordinated cell growth.
  • Aberrant activation of these pathways contributes to pathological tissue overgrowth.

Conclusions:

  • The PI3K/AKT/mTORC1 pathway is a key mediator of ribosome function in both physiological and pathological conditions.
  • Understanding the crosstalk between growth signaling pathways and ribosome regulation offers insights into disease mechanisms.
  • Targeting the PI3K/AKT/mTORC1 network presents a promising therapeutic strategy for diseases characterized by excessive tissue growth.

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...